Leukemia, Hairy Cell: all 113 studies
Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell LeukemiaCompletedNCT00074048Phase 2
- Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaCompletedNCT00058227Phase 1
- Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00025415Phase 1
- Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesCompletedNCT00014235Not applicable
- Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerCompletedNCT00006251Phase 1/2
- Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00005799Not applicable
- Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell LeukemiaCompletedNCT00005619
- Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine TherapyCompletedNCT00003757Phase 2
- Daily or Weekly Cladribine in Treating Patients With Hairy Cell LeukemiaCompletedNCT00003746Phase 3
- Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
- Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple MyelomaCompletedNCT00003196Not applicable
- A Phase II Efficacy Study of Roferon-A in Hairy Cell LeukemiaCompletedNCT00001567Phase 2